Pharmaron Beijing: Trading Debut, Valuation Scenario Analysis
Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...
415 Views
Pharmaron (康龙化成) A+H: Allocation and Thoughts on Trading
Pharmaron, the second-largest contract research organization (CRO), raised USD 560 m at HKD 39.50/share. In this insight, we will cover the...
441 Views
ECM Weekly (24 Nov 2019) - Alibaba, OneConnect, Tyro Payments, New Frontier Corp, AlphaMab
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Asia ECM...
470 Views
ECM Weekly (16 Nov 2019) - Alibaba, Freee, Megvii, Pharmaron, Canaan, XD
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Even as...
447 Views
Pharmaron Beijing IPO: H-Share Valuation Enticing
Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...
586 Views